Iodine Status of Mother-Infant Dyads from Montréal, Canada: Secondary Analyses of a Vitamin D Supplementation Trial in Breastfed Infants

Thumbnail image

Download files

DOI

https://doi.org/10.1093/jn/nxac047

Language of the publication
English
Date
2022-02-26
Type
Article
Author(s)
  • Bertinato, Jesse
  • Gaudet, Jeremiah
  • De Silva, Nimal
  • Mohanty, Smitarani
  • Cunye, Qiao
  • Matthew, Herod
  • Nathalie, Gharibeh
  • Hope, Weiler
Publisher
Elsevier

Abstract

Background Most pregnant or lactating women in Canada will not meet iodine requirements without iodine supplementation. Objectives To assess the iodine status of 132 mother-infant pairs based on secondary analyses of a vitamin D supplementation trial in breastfed infants from Montréal, Canada. Methods Maternal iodine status was assessed using the breastmilk iodine concentration (BMIC). Singleton, term-born infants were studied from 1–36 months of age. Usual (adjusted for within-person variation) iodine intakes were estimated from urinary iodine and creatinine concentrations. Iodine status was assessed using median urinary iodine concentrations (UICs) and by estimating inadequate intakes by the cut-point method using a proposed Estimated Average Requirement for infants 0–6 months of age (72 μg/d). Results At 1, 3, and 6 months of age, 70%, 63%, and 3% of infants, respectively, were exclusively breastfed. From 1–36 months of age (n = 82–129), the median UICs were ≥100 μg/L (range, 246–403 μg/L), which is the cutoff for adequate intakes set by the WHO for children <2 years. Almost all (98%–99%) infants at 1 and 2 months, 2 and 3 months, and 3 and 6 months of age had usual creatinine-adjusted iodine intakes ≥ 72 μg/d. The median BMIC was higher (P < 0.001) at 1 month compared to 6 months of lactation [1 month, 198 μg/kg (IQR, 124–274; n = 105) and 6 months, 109 μg/kg (IQR, 67–168; n = 78)]. At 1 and 6 months, 96% and 79% of mothers, respectively, had a BMIC ≥ 60 μg/kg, the lower limit of a normal reference range. The percentages of mothers that used a multivitamin-mineral (MVM) supplement containing iodine were 90% in pregnancy and 79% and 59% at 1 and 6 months of lactation, respectively. Conclusions The iodine status of infants was adequate throughout infancy. These results support a recommendation that all women who could become pregnant, who are pregnant, or who are breastfeeding take a daily MVM supplement containing iodine.

Subject

  • Health,
  • Health and safety

Download(s)

URI

Collection(s)

Safety of health products, food and veterinary drugs

Full item page

Full item page

Page details

Date modified: